activins has been researched along with Pulmonary Arterial Hypertension in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dunmore, BJ; Li, W; Morrell, NW; Upton, PD | 1 |
Emoto, N; Hara, T; Musthafa, A; Ryanto, GRT | 1 |
Humbert, M | 1 |
Emoto, N; Fujiyama, T; Guignabert, C; Hirata, KI; Humbert, M; Ikeda, K; Miyagawa, K; Ryanto, GRT; Tu, L; Yanagisawa, M | 1 |
2 review(s) available for activins and Pulmonary Arterial Hypertension
Article | Year |
---|---|
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.
Topics: Activins; Bone Morphogenetic Proteins; Cytokines; Humans; Hypertension, Pulmonary; Ligands; Pulmonary Arterial Hypertension; Pulmonary Artery; Signal Transduction | 2023 |
Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension.
Topics: Activins; Humans; Inhibins; Pulmonary Arterial Hypertension; Transforming Growth Factor beta | 2023 |
2 other study(ies) available for activins and Pulmonary Arterial Hypertension
Article | Year |
---|---|
Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension.
Topics: Activins; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Pulmonary Arterial Hypertension | 2023 |
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension.
Topics: Activins; Animals; Apoptosis; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Endocytosis; Endothelial Cells; Gene Knockout Techniques; Humans; Hypertension, Pulmonary; Hypoxia; Inhibin-beta Subunits; Inhibins; Lung; Mice; Mice, Inbred C57BL; Pulmonary Arterial Hypertension; Vascular Remodeling | 2021 |